Patents Assigned to Tiger Pharmatech
  • Protein kinase inhibitors
    Patent number: 8598184
    Abstract: The present invention is directed to low molecular weight and orally bioavailable 3H-[1,2,3]triazolo[4,5-d]pyrimidine derivatives, that are useful for treating cellular proliferative diseases, for treating disorders associated with MET activity, and for inhibiting the tyrosine kinase MET. The invention is also directed to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.
    Type: Grant
    Filed: February 28, 2009
    Date of Patent: December 3, 2013
    Assignee: Tiger Pharmatech
    Inventor: Junhu Zhang